Chu N F, Spiegelman D, Yu J, Rifai N, Hotamisligil G S, Rimm E B
Department of Epidemiology, Harvard School Public Health, Boston, MA, USA.
Int J Obes Relat Metab Disord. 2001 Mar;25(3):346-53. doi: 10.1038/sj.ijo.0801549.
Leptin, a primarily adipose tissue-derived protein product of the obesity (ob) gene, is an important regulator of energy metabolism. The strong association between body fat mass and elevated circulating leptin levels in humans suggests that leptin resistance, rather than leptin production, may contribute to the development of obesity and associated disorders. The purpose of this study is to evaluate the relationship between circulating plasma leptin levels and regulation of body weight over time among US men.
Four-year prospective study.
A total of 247 men from the Health Professionals Follow-up Study, who at baseline (1994), were 47-64 y of age, were free of cardiovascular diseases, diabetes mellitus and malignant neoplasmas, and completed a detailed lifestyle questionnaire. In addition, all participants completed a follow-up questionnaire in 1998.
Baseline plasma leptin levels and 4-y weight change.
At the start of follow-up, men in the highest quintile for plasma leptin (mean=12.1 ng/ml) weighed more, were less physically active, and had higher circulating insulin levels than men in the lowest quintile (mean=2.7 ng/ml). After adjustments for baseline age, weight, height, smoking status, alcohol intake, and physical activity, each 10 ng/ml increase in plasma leptin concentration was associated with a 1.68 kg (95% CI 0.14-3.18 kg) weight gain over the 4-y follow-up period. The observed association between leptin level and weight gain was limited to men with a baseline body mass index (BMI) of > or =25 kg/m2, in whom a 10 ng/ml higher baseline leptin was associated with a 2.45 kg (95% CI 0.73-4.18-kg) weight gain. Further adjustments for baseline total energy intake, plasma insulin and soluble tumor necrosis factor receptors levels did not appreciably alter these results. Plasma insulin level was not independently associated with subsequent weight gain.
These results suggest that elevated plasma leptin concentrations among overweight men may be a marker of leptin resistance and subsequent weight gain.
瘦素是肥胖(ob)基因主要在脂肪组织中产生的蛋白质产物,是能量代谢的重要调节因子。人体脂肪量与循环瘦素水平升高之间的紧密关联表明,导致肥胖及相关疾病的原因可能是瘦素抵抗,而非瘦素生成。本研究旨在评估美国男性循环血浆瘦素水平与体重随时间变化的调节之间的关系。
为期四年的前瞻性研究。
来自健康专业人员随访研究的247名男性,他们在基线期(1994年)年龄为47 - 64岁,无心血管疾病、糖尿病和恶性肿瘤,并完成了详细的生活方式问卷。此外,所有参与者在1998年完成了一份随访问卷。
基线血浆瘦素水平和4年体重变化。
在随访开始时,血浆瘦素水平处于最高五分位数的男性(平均 = 12.1 ng/ml)比处于最低五分位数的男性(平均 = 2.7 ng/ml)体重更重、身体活动更少且循环胰岛素水平更高。在对基线年龄、体重、身高、吸烟状况、酒精摄入量和身体活动进行调整后,血浆瘦素浓度每增加10 ng/ml,在4年随访期内体重增加1.68 kg(95%可信区间0.14 - 3.18 kg)。瘦素水平与体重增加之间的观察到的关联仅限于基线体重指数(BMI)≥25 kg/m²的男性,其中基线瘦素水平每高10 ng/ml,体重增加2.45 kg(95%可信区间0.73 - 4.18 kg)。对基线总能量摄入、血浆胰岛素和可溶性肿瘤坏死因子受体水平进行进一步调整后,这些结果没有明显改变。血浆胰岛素水平与随后的体重增加没有独立关联。
这些结果表明,超重男性血浆瘦素浓度升高可能是瘦素抵抗及随后体重增加的一个标志。